BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17953177)

  • 1. [Myocardial ischaemia as a result of treatment with capecitabine].
    van der Vliet HJ; Kuenen BC
    Ned Tijdschr Geneeskd; 2007 Sep; 151(36):2016; author reply 2016. PubMed ID: 17953177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myocardial ischaemia as a result of treatment with capecitabine].
    van Halteren HK; Liem AH; Planting AS
    Ned Tijdschr Geneeskd; 2007 Jun; 151(26):1469-73. PubMed ID: 17633978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine induced cardiotoxicity: a case report and review of literature.
    Tunio MA; Hashmi A; Shoaib M
    Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine may induce coronary artery vasospasm.
    Tsiamis E; Synetos A; Stefanadis C
    Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stevens-Johnson syndrome after treatment with capecitabine.
    Sendur MA; Kilickap S
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):202-3. PubMed ID: 18160271
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe hypertriglyceridaemia associated with the use of capecitabine.
    Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
    Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prinzmetal's angina in a patient treated with capecitabine: a case study].
    Becerril Moreno F; González Sanchez J; Arteche Eguizabal L
    Farm Hosp; 2010; 34(5):262-4. PubMed ID: 20167524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxic dermatitis due to capecitabine: presentation of 2 cases and literature review].
    Gutiérrez-Pascual M; Sols-Candela M; Pinedo F; López-Estebaranz JL
    Actas Dermosifiliogr; 2009 May; 100(4):336-8. PubMed ID: 19463243
    [No Abstract]   [Full Text] [Related]  

  • 9. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute coronary syndrome during oral capecitabine monotherapy].
    Martí V; Monell J; Seixo F; Falces C
    Rev Esp Cardiol; 2008 May; 61(5):548-9. PubMed ID: 18462663
    [No Abstract]   [Full Text] [Related]  

  • 11. Capecitabine induced vasospastic angina.
    Coughlin S; Das S; Lee J; Cooper J
    Int J Cardiol; 2008 Oct; 130(1):e34-6. PubMed ID: 17897740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute coronary syndrome in patient treated with capecitabine].
    Garcipérez de Vargas FJ; Gómez Barrado JJ; Mendoza Vázquez J; Ortiz Cortés C
    Med Clin (Barc); 2012 Jan; 138(1):43-4. PubMed ID: 21696784
    [No Abstract]   [Full Text] [Related]  

  • 13. Inflammation of actinic keratoses and acral erythrodysesthesia during capecitabine treatment.
    Peramiquel L; Dalmau J; Puig L; Roé E; Fernández-Figueras MT; Alomar A
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S119-20. PubMed ID: 17052530
    [No Abstract]   [Full Text] [Related]  

  • 14. Capecitabine induced inflammation of actinic keratoses.
    Krathen M; Treat J; James WD
    Dermatol Online J; 2007 Oct; 13(4):13. PubMed ID: 18319010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine-induced acute myeloid leukaemia.
    Tansley S; Gibbons S
    N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
    [No Abstract]   [Full Text] [Related]  

  • 16. [The prevention of diarrhea while under capecitabine therapy].
    Grouls V
    Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1750. PubMed ID: 18696410
    [No Abstract]   [Full Text] [Related]  

  • 17. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
    Dalmau J; Roé E; Puig L; Alomar A
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
    [No Abstract]   [Full Text] [Related]  

  • 18. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 19. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine.
    Merlin F; Prochilo T; Kildani B; Lombardi C; Pasolini G; Bonetti F; Beretta GD
    Int J Colorectal Dis; 2008 Jul; 23(7):715-6. PubMed ID: 18330579
    [No Abstract]   [Full Text] [Related]  

  • 20. Longitudinal melanonychia induced by capecitabine.
    Paravar T; Hymes SR
    Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.